Human medicines European public assessment report (EPAR): Elahere, mirvetuximab soravtansine, Date of authorisation: 14/11/2024, Revision: 2, Status: Authorised

Demonstration of efficacy of ectoparasiticides - Scientific guideline

PDCO work plan 2026

Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Date of authorisation: 30/06/2015, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Vyvgart, efgartigimod alfa, Date of authorisation: 10/08/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation: 15/11/2017, Revision: 16, Status: Authorised

Ilona Reischl re-elected as chair of Committee for Advanced Therapies

Concept paper on the development of a guideline for using owner assessment as efficacy parameter

Owner assessment as efficacy parameter - Scientific guideline

Veterinary medicinal products controlling Varroa destructor parasitosis in bees - Scientific guideline